Iovance Biotherapeutics
IOVA
IOVA
84 hedge funds and large institutions have $349M invested in Iovance Biotherapeutics in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 9 closing their positions.
Holders
84
Holders Change
+3
Holders Change %
+3.7%
% of All Funds
2.1%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
13
Increased
26
Reduced
30
Closed
9
Calls
$3.43M
Puts
$186K
Net Calls
+$3.25M
Net Calls Change
+$2.19M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$8.01M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$32.1M |
| 3 |
3
Millennium Management
New York
|
$3.16M |
| 4 |
GPP
4
Great Point Partners
Greenwich,
Connecticut
|
$1.24M |
| 5 |
NFA
5
Nationwide Fund Advisors
Columbus,
Ohio
|
$1.02M |
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$20.8M |
| 2 |
QF
2
QVT Financial
New York
|
$4.69M |
| 3 |
GTC
3
Ghost Tree Capital
New York
|
$4.04M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$2.22M |
| 5 |
ACA
5
Avoro Capital Advisors
New York
|
$30.5M |
